Nanovis

纳诺维斯

announced today that it sold certain nano surface technology assets and certain IP rights to

今天宣布，它将某些纳米表面技术资产和某些知识产权出售给

Medtronic

美敦力

(NYSE: MDT)

（纽约证券交易所：MDT）

+

+

.

.

Columbia City, Indiana–based Nanovis said Medtronic acquired the nano surface technology assets and certain rights to IP assets related to Sites Medical’s OsteoSync titanium pads. The medtech giant made the acquisition for use in the development of its next-generation PEEK interbody fusion devices.

总部位于印第安纳州哥伦比亚市的Nanovis表示，美敦力收购了纳米表面技术资产以及与Sites Medical的OsteoSync钛垫相关的某些知识产权资产。这家医疗科技巨头进行了此次收购，用于开发其下一代PEEK椎间融合装置。

“We are excited about our collaboration with Medtronic,” said

“我们对与美敦力的合作感到兴奋，”他说

Brian More

布莱恩·莫尔

, CEO of Nanovis. “Combining our market-leading nano surface technology with Medtronic’s market-leading PEEK implant designs will give a growing number of surgeons access to best-in-class devices to treat patients.”

，Nanovis首席执行官。“将我们市场领先的纳米表面技术与美敦力市场领先的PEEK植入物设计相结合，将使越来越多的外科医生能够使用一流的设备治疗患者。”

Financial terms of the deal were not disclosed.

交易的财务条款未披露。

Nanovis said its bone-growth nanotechnology can improve the speed and consistency of the human bone growth response. It enhances implant fixation through osseointegration. In this process, the bone grows and fuses with the surface of a spinal implant.

Nanovis表示，其骨骼生长纳米技术可以提高人体骨骼生长反应的速度和一致性。它通过骨整合增强植入物固定。在这个过程中，骨骼生长并与脊柱植入物的表面融合。

Medtronic develops interbody systems based on polyetheretherketone (PEEK). For instance, the company’s Infuse bone graft has FDA approval for specific spine, oral-maxillofacial and orthopedic trauma procedures. In spine surgery, it works with select Medtronic interbody fusion devices.

美敦力开发了基于聚醚醚酮（PEEK）的椎间系统。例如，该公司的Infuse骨移植物已获得FDA批准用于特定的脊柱，口腔颌面和骨科创伤手术。在脊柱手术中，它与选定的美敦力椎间融合装置配合使用。

“This collaboration is a testament to the significance of the nano surface technology we developed and the value it delivers to our customers and to patients,” said More. “Medtronic’s commitment to innovation and commercial scale makes them an ideal partner to take these technologies to market.”

More说：“这次合作证明了我们开发的纳米表面技术的重要性，以及它为我们的客户和患者带来的价值。”。“美敦力致力于创新和商业规模，使其成为将这些技术推向市场的理想合作伙伴。”